704 related articles for article (PubMed ID: 23402241)
1. [The disease burden of human papillomavirus in men is substantial and can potentially be prevented].
Kiellberg Larsen H; Kofoed K; Sand C
Ugeskr Laeger; 2013 Feb; 175(6):349-53. PubMed ID: 23402241
[TBL] [Abstract][Full Text] [Related]
2. The HPV infection in males: an update.
Giraldi G; De Luca d'Alessandro E
Ann Ig; 2012; 24(6):497-506. PubMed ID: 23234187
[TBL] [Abstract][Full Text] [Related]
3. Beyond cervical cancer: burden of other HPV-related cancers among men and women.
Chaturvedi AK
J Adolesc Health; 2010 Apr; 46(4 Suppl):S20-6. PubMed ID: 20307840
[TBL] [Abstract][Full Text] [Related]
4. Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis.
Bogaards JA; Wallinga J; Brakenhoff RH; Meijer CJ; Berkhof J
BMJ; 2015 May; 350():h2016. PubMed ID: 25985328
[TBL] [Abstract][Full Text] [Related]
5. Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Dec; 60(50):1705-8. PubMed ID: 22189893
[TBL] [Abstract][Full Text] [Related]
6. [The human papillomavirus vaccine: is it of value in dermatology?].
Pedragosa-Jové R; Salleras-Redonet M;
Actas Dermosifiliogr; 2012 Mar; 103(2):92-3. PubMed ID: 22296714
[No Abstract] [Full Text] [Related]
7. Global burden of human papillomavirus and related diseases.
Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S
Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955
[TBL] [Abstract][Full Text] [Related]
8. Impact of prophylactic human papillomavirus vaccines on dermatology and venereology.
Gross G
G Ital Dermatol Venereol; 2008 Aug; 143(4):259-65. PubMed ID: 18833082
[TBL] [Abstract][Full Text] [Related]
9. [The first vaccine against cancer: the human papillomavirus vaccine].
Bősze P
Orv Hetil; 2013 Apr; 154(16):603-18. PubMed ID: 23587540
[TBL] [Abstract][Full Text] [Related]
10. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
Goldstone SE; Vuocolo S
Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
[TBL] [Abstract][Full Text] [Related]
11. Acceptability of HPV vaccines and perceptions related to genital warts and penile/anal cancers among men who have sex with men in Hong Kong.
Wang Z; Mo PK; Lau JT; Lau M; Lai CH
Vaccine; 2013 Sep; 31(41):4675-81. PubMed ID: 23845815
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus.
Broomall EM; Reynolds SM; Jacobson RM
Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463
[TBL] [Abstract][Full Text] [Related]
13. Cancers attributable to human papillomavirus infection.
Grulich AE; Jin F; Conway EL; Stein AN; Hocking J
Sex Health; 2010 Sep; 7(3):244-52. PubMed ID: 20719211
[TBL] [Abstract][Full Text] [Related]
14. Should my son get an HPV vaccine?
Stabb JE; Buckley R
JAAPA; 2011 Jan; 24(1):53. PubMed ID: 21261150
[No Abstract] [Full Text] [Related]
15. HPV vaccination in boys and men.
Stanley M
Hum Vaccin Immunother; 2014; 10(7):2109-11. PubMed ID: 25424825
[TBL] [Abstract][Full Text] [Related]
16. HPV vaccine update: new indications and controversies.
Mendoza N; Hernandez PO; Tyring SK
Skin Therapy Lett; 2011 Sep; 16(8):1-3. PubMed ID: 22089414
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus-related disease in men: not just a women's issue.
Palefsky JM
J Adolesc Health; 2010 Apr; 46(4 Suppl):S12-9. PubMed ID: 20307839
[TBL] [Abstract][Full Text] [Related]
18. Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods.
Watson M; Saraiya M; Ahmed F; Cardinez CJ; Reichman ME; Weir HK; Richards TB
Cancer; 2008 Nov; 113(10 Suppl):2841-54. PubMed ID: 18980203
[TBL] [Abstract][Full Text] [Related]
19. 9-Valent HPV vaccine for cancers, pre-cancers and genital warts related to HPV.
Pitisuttithum P; Velicer C; Luxembourg A
Expert Rev Vaccines; 2015; 14(11):1405-19. PubMed ID: 26366475
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological dynamic modeling of human papillomavirus-related diseases to assess vaccination strategies in Argentina.
Borracci RA; Segal SV; Méndez JH
Medicina (B Aires); 2018; 78(5):315-328. PubMed ID: 30285924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
